Stock PPLPHARMA PIRAMAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Piramal Pharma Limited Bombay S.E.

Equities

PPLPHARMA

INE0DK501011

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-07-09 am EDT 		5-day change 1st Jan Change
155.7 INR +0.81% Intraday chart for Piramal Pharma Limited -1.67% +12.18%
May. 14 Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy MT
May. 13 Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

Business Summary

Piramal Pharma Limited is an India-based pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. The Company has approximately 17 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain, anesthetics, injectable anti-infectives, and other therapies.

Number of employees: 6,719

Sales per Business

INR in Million2023Weight2024Weight Delta
Contract Development and Manufacturing Organisation
58.0 %
- - 47,393 58.0 % -
Inhalation Anesthesia
20.1 %
14,503 20.5 % 16,424 20.1 % +13.25%
Intrathecal Therapy
4.5 %
3,399 4.8 % 3,677 4.5 % +8.17%
Injectable Anesthesia and Pain Management
3.0 %
2,493 3.5 % 2,451 3.0 % -1.66%
Kids Wellness
2.8 %
1,870 2.6 % 2,255 2.8 % +20.63%
Other Generic and Specialty Products
2.4 %
2,266 3.2 % 1,961 2.4 % -13.46%
Skin Care
2.3 %
1,785 2.5 % 1,863 2.3 % +4.40%
Analgesic
2.3 %
1,700 2.4 % 1,863 2.3 % +9.62%
Multivitamin
1.8 %
1,275 1.8 % 1,471 1.8 % +15.39%
Other India Consumer Healthcare
1.2 %
425 0.6 % 981 1.2 % +130.77%
Gastro Intestinal
0.8 %
595 0.8 % 686 0.8 % +15.39%
Women's Health
0.8 %
680 1.0 % 686 0.8 % +0.96%

Sales per region

INR in Million2023Weight2024Weight Delta
North America
41.0 %
31,867 45.0 % 33,502 41.0 % +5.13%
Europe
25.0 %
14,163 20.0 % 20,428 25.0 % +44.23%
India
20.0 %
14,163 20.0 % 16,342 20.0 % +15.39%
Others
10.0 %
7,790 11.0 % 8,171 10.0 % +4.90%
Japan
4.0 %
2,833 4.0 % 3,268 4.0 % +15.39%

Managers

Managers TitleAgeSince
Peter DeYoung CEO
 Chief Executive Officer 46 20-03-03
Vivek Valsaraj PSD
 President 51 20-06-09
Vinay Agrawal COO
 Chief Operating Officer 60 20-04-04
Gagan Borana IRC
 Investor Relations Contact - -
Prasanth M. S. SAM
 Sales & Marketing 51 20-06-09
Vikram Duggal HRO
 Human Resources Officer 50 20-01-07
Sameer Penkar SAM
 Sales & Marketing - 20-06-09
Tanya Smiley DCosta SEC
 Corporate Secretary - 20-03-03
Rashida Najmi PRN
 Corporate Officer/Principal 58 -

Members of the board

Members of the board TitleAgeSince
Nandini Ajay Piramal CHM
 Chairman 43 21-01-03
Neeraj Bharadwaj BRD
 Director/Board Member 55 -
Subramanian V. Ramadorai BRD
 Director/Board Member 76 21-02-08
Sridhar Ananta Bhanu Gorthi BRD
 Director/Board Member 52 22-03-29
Vibha Paul Rishi BRD
 Director/Board Member 64 22-09-28
Jairaj Manohar Purandare BRD
 Director/Board Member 65 21-02-08
Peter DeYoung CEO
 Chief Executive Officer 46 20-03-03
Vivek Valsaraj PSD
 President 51 20-06-09
Peter Stevenson BRD
 Director/Board Member - 22-03-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,320,816,324 354,235,407 ( 26.82 %) 0 26.82 %

Shareholders

NameEquities%Valuation
Ajay Gopikisan Piramal
27.64 %
366,431,784 27.64 % 690 M ₹
The Carlyle Group LP (Global Credit)
18.43 %
244,374,445 18.43 % 460 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
5.653 %
74,945,455 5.653 % 141 M ₹
East Bridge Capital Management L.P.
5.181 %
68,680,593 5.181 % 129 M ₹
V3 Designs LLP
3.323 %
44,054,349 3.323 % 83 M ₹
The Caisse de dépôt et placement du Québec
3.267 %
43,309,424 3.267 % 82 M ₹
Prl Realtors LLP
3.074 %
40,752,489 3.074 % 77 M ₹
Canara Robeco Asset Management Co. Ltd.
0.8950 %
11,864,889 0.8950 % 22 M ₹
PIRAMAL ENTERPRISES LIMITED
0.8172 %
10,834,462 0.8172 % 20 M ₹
Alpex Holdings Pvt Ltd.
0.6898 %
9,145,443 0.6898 % 17 M ₹

Company contact information

Piramal Pharma Ltd.

507, Skyline Wealth Space, 5th Floor C2 Wing, Skyline Oasis Complex

400086, Mumbai

+91 22 3802 3000

http://www.piramal.com/businesses/piramal-pharma/
address Piramal Pharma Limited(PPLPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Piramal Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
155.8 INR
Average target price
182 INR
Spread / Average Target
+16.84%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+59.97% 827B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.38% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.18% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.61% 319B
ABBVIE INC. Stock AbbVie Inc.
+8.44% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.68% 240B
NOVARTIS AG Stock Novartis AG
+14.40% 221B
ROCHE HOLDING AG Stock Roche Holding AG
+0.04% 219B
AMGEN INC. Stock Amgen Inc.
+9.68% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PPLPHARMA Stock
  4. PPLPHARMA Stock
  5. Company Piramal Pharma Limited